Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for Post-Partum Pain Following Obstetrical Laceration
NCT03152877Completed
- Sponsor
- Walter Reed National Military Medical Center
- Start
- Mar 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine in Postpartum pain (PPP) (2 arms), sponsored by Walter Reed National Military Medical Center. Primary endpoint: Postpartum pain control (Visual Analogue Scale) at 7 days. Started Mar 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
Postpartum pain (PPP)
Beyond the preview
Go deeper on NCT03152877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03152877.